MeSH note : a combination chemotherapy protocol consisting of a myelosuppressive phase (ifosfamide,
mesna, etoposide, mitoxantrone) and a non-myelosuppressive phase (bleomycin, vincristine,
prednisone); used in the treatment of non-Hodgkin's lymphoma;